Derma Sciences, Inc. (DSCI)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stephen T. Wills
Employees:
260
214 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ 08540
6095144744

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Derma Sciences, Inc. operates as a medical device company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wo...

Data derived from most recent annual or quarterly report
Market Cap 197.885 Million Shares Outstanding28.269 Million Avg 30-day Volume 99.4 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.08
Price to Revenue1.4851 Debt to Equity0.3743 EBITDA-6.846 Million
Price to Book Value1.1744 Operating Margin-17.2577 Enterprise Value117.696 Million
Current Ratio1.293 EPS Growth0 Quick Ratio0.982
1 Yr BETA 0.9259 52-week High/Low 0.0 / Profit Margin8.2399
Operating Cash Flow Growth63.0766 Altman Z-Score0.4383 Free Cash Flow to Firm -65.266 Million
View SEC Filings from DSCI instead.

View recent insider trading info

Derma Sciences, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding DSCI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DSCI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-24 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-16 by DERMA SCIENCES, INC.
  • 4: filed on 2017-02-16 by DERMA SCIENCES, INC.

    • Events (8k)

  • 8-K/A: filed on 2017-03-07:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-02-24:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-01-25:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2017-01-17:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-01-17:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2016-10-21:
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-09-08:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-08-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2016-08-11:
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-08-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MOUSSA ROBERT G

    • Director
    		 No longer subject to file 2017-02-24 0

    CONJEEVARAM SRINI

    • Director
    		 No longer subject to file 2017-02-24 0

    WILLS STEPHEN T

    • Director
    • EXECUTIVE CHAIRMAN
    		 No longer subject to file 2017-02-24 0

    COLE ROBERT C SEE REMARKS

    • Officer
    		 No longer subject to file 2017-02-24 0

    YETTER JOHN E EVP, FINANCE & CFO

    • Officer
    		 No longer subject to file 2017-02-24 0

    NAVARRO SAMUEL E

    • Director
    		 No longer subject to file 2017-02-24 0

    EIGNER FREDERIC EXECUTIVE VP - OPERATIONS

    • Officer
    		 No longer subject to file 2017-02-24 0

    HEWLETT BRETT

    • Director
    		 No longer subject to file 2017-02-24 0

    WOLFENSON BARRY

    • SEE REMARKS
    		 No longer subject to file 2016-07-31 0

    WESSON BRUCE F

    • FORMER DIRECTOR
    		 0 2016-05-31 0

    PAUL AMY S

    • FORMER DIRECTOR
    		 0 2016-05-31 0

    QUILTY EDWARD J FORMER PRESIDENT & CEO

    • Officer
    		 192,396 2015-12-20 0

    STAFFORD C RICHARD

    • FORMER DIRECTOR
    		 0 2015-05-27 0

    CAMINIS JOHN CHIEF MEDICAL OFFICER

    • Officer
    		 0 2015-03-09 0

    RA CAPITAL MANAGEMENT, LLC

    KOLCHINSKY PETER

    RA CAPITAL HEALTHCARE FUND LP

    • FMR 10% OWNER - SEE FN (1)-(5)FMR 10% OWNER - SEE FN (1)-(5)FMR 10% OWNER - SEE FN (1)-(5)
    		 No longer subject to file 2014-01-10 0

    MARTIN WILLIAM C

    RAGING CAPITAL MANAGEMENT, LLC

    RAGING CAPITAL MASTER FUND, LTD.

    • 10% Owner
    		 No longer subject to file 2013-05-28 0

    GILBERT PAUL M

    • Director
    • SEE REMARKS
    		 15,000 2013-05-23 0

    OBRIEN JAMES T

    • FORMER DIRECTOR
    		 No longer subject to file 2013-03-29 0

    MARTIN WILLIAM C

    RAGING CAPITAL MANAGEMENT, LLC

    RAGING CAPITAL FUND, LP

    RAGING CAPITAL FUND (QP), LP

    • 10% Owner
    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		 0 2013-01-01 0

    RAGING CAPITAL MASTER FUND, LTD.

    • 10% Owner
    		 1,332,557 2013-01-01 0

    KEIM RICHARD

    • FORMER DIRECTOR
    		 No longer subject to file 2012-05-30 0

    LEHMAN BROTHERS HOLDINGS INC

    • 10% Owner
    		 803,570 2012-02-06 0

    COMVITA LTD

    • 10% Owner
    		 864,880 2011-04-29 0

    COMVITA NEW ZEALAND LTD

    • 10% Owner
    		 No longer subject to file 2010-03-31 0

    RIVEST DANIEL EXEC. VP - FIRST AID PRODUCTS

    • Officer
    		 0 2009-03-31 0

    GALEN PARTNERS III L P

    • 10% Owner
    		 1,474,345 2007-01-05 0

    GALEN PARTNERS INTERNATIONAL III L P

    • SEE FOOTNOTE (1)
    		 133,777 2007-01-05 0

    GALEN EMPLOYEE FUND III LP

    • SEE FOOTNOTE (1)
    		 6,053 2007-01-05 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments